Peter Salgo, MD, and the panelists discuss how barriers are currently affecting a physician’s decision to treat and manage obese patients despite the American Medical Association’s 2013 decision to recognize obesity as a disease.
Yehuda Handelsman, MD, FACP, FACE, FNLA, explains that although obesity is recognized as a disease, he is unable to properly manage his patients’ obesity because if he were to diagnose a patient for it, he would not be reimbursed. More than just metabolic issues, patients who are obese often have joint problems, breathing difficulties, and overall mobility problems that may require surgeries. Dr Handelsman further explains that physicians need to be able to manage patients in ways similar to how patients are managed for other chronic diseases.
Jeffrey D. Dunn, PharmD, MBA, adds that not every party will approach obesity in the same way. Dr Dunn explains that from a payer perspective, the focus on improving the management of obesity begins with leveling the playing field and establishing coordination between the different stakeholders.
Maria Lopes, MD, MS, discusses how physicians need access to better patient engagement resources and behavior modification tools. She adds that professionals need to gain access to resources that help them understand which treatment methods work and which ones don’t.
Dr Dunn concludes the discussion by explaining why the provider, patient, and payer need to work together to combat these issues and spread the risk.
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for HHS leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
The White House has called out the Republican Study Committee’s budget proposal for backing legislation that would put restrictions on abortion access; nearly 108,000 Americans died of drug overdoses in 2022; surgeons in Boston have transplanted a kidney from a genetically engineered pig into an ailing 62-year-old man.
Read More
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More